Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Nov 6, 2016; 7(4): 469-476
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.469
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.469
Figure 1 Bilirubin metabolism (from heme to bilirubin).
Hemoglobin is cleaved to yield globin and heme (red). Heme is enzymatically converted to biliverdin (green) by liberating iron, via oxidation with loss of a carbon atom (CO). This, in turn, yields bilirubin (orange) after enzymatic reduction of biliverdin. In the liver, bilirubin is conjugated to enable excretion, requiring the enzyme UGT1A1[4].
- Citation: Gupta N, Singh T, Chaudhary R, Garg SK, Sandhu GS, Mittal V, Gupta R, Bodin R, Sule S. Bilirubin in coronary artery disease: Cytotoxic or protective? World J Gastrointest Pharmacol Ther 2016; 7(4): 469-476
- URL: https://www.wjgnet.com/2150-5349/full/v7/i4/469.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i4.469